Extreme thrombocytosis in a young cat.

Comp Clin Path

Tierklinik Meidling, Vienna, Austria.

Published: June 2010

A 7-month-old unvaccinated domestic shorthair cat was presented with a history of inappetence and hypersalivation. Clinical examination revealed fever, gingivitis and oral ulceration. An initial blood sample revealed a severe leukopenia and neutropenia and a feline panleukopenia virus (FPV) titre of 1:640; a second titre 10 days later was 1:2,560. A feline calicivirus (FCV) titre was 1:320 and the initial clinical signs and laboratory findings were attributed to a coinfection with FPV and FCV. The cat was treated with interferon omega. A blood sample taken 10 days later revealed a severe thrombocytosis of 3,448 × 10/L (reference range 200-500 × 10/L) confirmed by blood smear examination. The platelet count on day 35 was 4,990 × 10/L. No bone marrow examination was carried out. Two differential diagnoses for an extreme thrombocytosis are a reactive thrombocytosis or essential thrombocythemia (ET). ET is a hemic neoplasia that causes a severe and persistent thrombocytosis, and is a diagnosis of exclusion. Reactive thrombocytosis is generally mild to moderate and of shorter duration than described here, but an excessive response could have been caused by infection. The influence of additional factors such as an initial thrombocytopenia, age and interferon treatment are not clear but can be speculated on. Although the exact pathophysiology in this case remains unclear, such high, persistent thrombocyte numbers have not been reported in cats in the absence of a neoplastic process.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087589PMC
http://dx.doi.org/10.1007/s00580-010-1036-zDOI Listing

Publication Analysis

Top Keywords

extreme thrombocytosis
8
blood sample
8
revealed severe
8
reactive thrombocytosis
8
thrombocytosis
5
thrombocytosis young
4
young cat
4
cat 7-month-old
4
7-month-old unvaccinated
4
unvaccinated domestic
4

Similar Publications

Essential thrombocythemia (ET) is a type of myeloproliferative neoplasm (MPN) disorder characterized by persistent thrombocytosis and characterized by frequent association with cellular genetic alterations. The 10%-15% of ET that is not associated with genetic abnormalities is known as triple-negative essential thrombocythemia (TNET). A common complication observed in around 20% of ET patients is the development of acquired von Willebrand disease (AvWD).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between elevated vitamin B12 levels and myeloproliferative neoplasms (MPNs), which include types of blood cancers like CML, PV, MF, and ET, suggesting that higher B12 could indicate disease presence and activity.
  • Data from 467 MPN patients showed that 20% had elevated B12 levels, particularly in those with CML, with significant reductions in B12 levels observed after one year of treatment.
  • While increased B12 levels appear related to MPN activity, their effectiveness as a consistent diagnostic marker needs more research to establish reliable sensitivity, specificity, and cutoff values.
View Article and Find Full Text PDF

is an opportunistic bacterium that is often identified in asymptomatic, healthy individuals from colonization of the genitourinary tract. However, in immunocompromised patients with hypogammaglobulinemia, has been reported to cause a wide range of infections, most commonly urethritis and cystitis. The absence of a bacterial cell wall prevents from being cultured using routine bacteriologic media and makes it resistant to commonly prescribed antibiotics.

View Article and Find Full Text PDF
Article Synopsis
  • - Polycythemia vera (PV) is a rare blood disorder affecting around 65,000 Americans, characterized by an increased mass of red blood cells, leading to a higher risk of blood clots, with symptoms such as itching and enlarged spleen.
  • - Diagnosis often involves identifying elevated hemoglobin levels and the presence of a specific JAK2 gene variant, with many patients also experiencing increased platelet and white blood cell counts; survival rates range from 14 to 28 years following diagnosis.
  • - Treatment typically includes therapeutic phlebotomy and low-dose aspirin for thrombosis prevention, with higher-risk patients possibly receiving additional therapies like hydroxyurea or Ruxolitinib for symptom relief; a small percentage may
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!